 phase i/ii trial zidovudin interferon-alpha granulocyte-macrophag colony-stimul factor treatment human immunodefici viru type infect patient human immunodefici viru type count cells/l granulocyte-macrophag colony-stimul factor gm-csf combin zidovudin escal dose daili subcutan interferon-alpha mean neutropenia-induc dose interferon-alpha iu/day group mg mean gm-csf dose neutropenia microgram/kg/day group mean minimum effect gm-csf dose microgram/kg/day serum antigen antigenem patient toxic dose-depend increas lymphokine-lik side effect anorexia weight loss fatigu anemia toxic combin signific low-dos gm-csf zidovudin interferon-alpha therapi antivir properti combin